Latest Biotech Multi-bagger Stock Picks from BioRunUp

Now, the key risk remains in shape of a denial from FDA to launch the drug, and this factor alone boosts speculation activity in stock prices.

This is where BioRunUp, a leading stock research & analysis services provider comes into play. As we know that FDA’s decision date on a drug’s license is known at least six months in advance, so the company works on a run up methodology and identifies pockets of opportunities in biotech companies. They target companies whose stock prices can rise till the final ruling from FDA comes into action.

Well, this is not an easy task for any analysis firm and simply way beyond individuals’ capabilities. BioRunUp’s research and analysis process is conducted through various methods. These include:-

• Paid Subscription Services
• SEC Filings
• Researching company specific information through News Feeds, Bulletin Boards, Forums and Official Websites
• Evaluating demand for the dug and identifying its potential markets
• Studying factors such as company’s market cap and its cash position
• Identifying any factors that could lead to a denial for license from FDA

All this is not easy and requires hours of reasoning and research. That is the reason such a service cannot be offered free of charge. However, BioRunUp charges a nominal fee for the access to their advisory services, which is available in two packages:

Subscribe for Annual Plan at $295

Subscribe for Monthly Plan $49.95

Key Features for Paid Subscribers at BioRunUp

• They offer comprehensive reports of any upcoming clinical trials
• Regular updated Analyst Reports
• Subscribers receive Weekly Newsletters
• They offer critical news alert service through Email and SMS
• Access  to forums, creating a community of informed traders
• BioRunUp has a venture with mikehavRx dot com to offer joint services to subscribers
• Detailed PDF reports linked to FDA calendar
• They even provide access to historical FDA Reports
• One of their best feature is the Live Newsfeed exclusively for paid members
• Traders can track Mike Havrilla’s portfolio investments and his watch list and the service also includes performance stats from profit.ly
• It also offers access to Google Calendar of Corporate events for tracking Bio-catalyst stocks
• They have built a unique rating system to grade catalysts and also offer a managed tracking service for upcoming catalysts.

That’s not all; BioRunUp offers direct email communication option to individual clients and are prompt in dealing with queries.

Above all, BioRunUp invites all of its members to profit from the growth of their business, and thus offers $50 for every referral signup.

Signup to receive $50/Referral

Read More:-

What should be your Investment Strategy for 2011?

Don’t just Trade: How to Grow Wealth Systematically?